微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.78% | 10.56% | -63.52% | 59/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 4.88% | -1.01% | -7.92% | 60/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 5.3% | 22.69% | 162.38% | 58/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.02% | -25.74% | 25.47% | 82/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.61% | 21.05% | -67.34% | 67/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 4.93% | 10.79% | 14.12% | 59/157 | -9.62% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 4.32% | -14.46% | 58.82% | 68/157 | 4.28% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.72% | -10.82% | 104.51% | 67/157 | 2.69% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.33% | -38.71% | -70.11% | 81/157 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.45% | -52.61% | -11.88% | 67/157 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.05% | -17.08% | 65.57% | 69/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.05% | -37.11% | 40.55% | 67/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.17% | 83.9% | -76.89% | 57/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 9.39% | 9.44% | 54.19% | 46/157 | 0.79% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 6.09% | -35.21% | 25.57% | 56/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.85% | 15.48% | 311.02% | 47/157 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.18% | -48.02% | -86.25% | 85/157 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 8.58% | 6.72% | -8.72% | 50/157 | 0.84% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 9.4% | 25% | 123.81% | 36/157 | 4.46% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.2% | 4.48% | 85.02% | 67/157 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.27% | 25.41% | -71.77% | 61/157 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 8.04% | 3.47% | 6.91% | 68/157 | 3.8% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.52% | 4.3% | 87.06% | 52/157 | 3.13% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.02% | -2.43% | 122.1% | 65/157 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 1.81% | -27.89% | -76.71% | 52/157 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 7.77% | -1.89% | 7.77% | 71/157 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 7.21% | -9.88% | 75% | 49/157 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.12% | -12.53% | 64.14% | 60/157 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.51% | -13.45% | -68.31% | 43/157 | 2.45% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 7.92% | -18.94% | -1% | 66/157 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8% | -21.95% | 69.85% | 39/157 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.71% | -15.89% | 62.41% | 44/157 | 4.63% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.9% | -12.12% | -70.32% | 32/157 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 9.77% | -8.09% | -4.68% | 49/157 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 10.25% | -10.64% | 83.04% | 26/157 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 5.6% | -7.28% | 69.7% | 35/157 | 5.56% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.3% | -3.51% | -68.96% | 21/157 | 2.1% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 10.63% | 11.08% | -7.32% | 50/157 | 6.05% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 11.47% | 3.71% | 89.9% | 20/157 | 5.64% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 6.04% | 19.13% | 76.61% | 33/157 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.42% | 9.27% | -64.26% | 21/157 | 2.69% | 贝达药业 | 16.78% | 行业排名> |